Bio-Techne to acquire Namocell

Bio-Techne Corporation reached an agreement to acquire Namocell, a provider of single cell sorting and dispensing platforms, to complement its Cell and Gene Therapy franchise.

“Namocell is very complementary to Bio-Techne's existing Cell and Gene Therapy franchise and we anticipate significant commercial synergies.”prnewswire.com

• 1 source
• prnewswire.comBIO-TECHNE TO ACQUIRE NAMOCELLBio-Techne CorporationJun 22, 2022

Summarized from public sources; check the original articles before acting on it.